Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload
John A. Muraski(San Diego State University), Mark A. Sussman(California Institute for Regenerative Medicine), Marcello Rota(New York Medical College), S. R HOUSER(Temple University), Pearl Quijada(Broad Center), Christopher T. Cottage(San Diego State University), Roberto Baelo Álvarez(San Diego State University), Erik Schaefer, Scott MacDonnel(Temple University), Kimberlee M. Fischer(San Diego State University), Nancy S. Magnuson(Washington State University), Natalie Gude(San Diego State University), Xiongen Chen(Temple University), Jan Kajstura(LifeArc), Weitao Wu(San Diego State University), Piero Anversa(New York Medical College), Shabana Din(San Diego State University), Zeping Wang(Washington State University), Matt Mason(San Diego State University)
Cited by 63
Related Papers
Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth.
|Circulation Research|1986|280
Pim kinase-dependent inhibition of c-Myc degradation
|Oncogene|2008|272
Pim-1: A serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis
|Journal of Veterinary Science|2001|268
Pim-1 regulates cardiomyocyte survival downstream of Akt
|Nature Medicine|2007|239
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
|Journal of Clinical Investigation|2005|230